Prenatal Antipsychotic Medication Exposure Appears Not To Result In Increased Risk For AD/HD, ASD, Or Being Small For Gestational Age, Study Indicates

MedPage Today (8/16, Monaco) reports, “Use of antipsychotics during pregnancy did not seem to have a significant developmental impact on babies,” researchers concluded “in an analysis of more than 300,000 mother-child pairs.” The study revealed that children of mothers “who were taking an antipsychotic during pregnancy showed no increased risk for developing” attention-deficit/hyperactivity disorder (AD/HD) or autism spectrum disorder (ASD), “or of being born small for gestational age.” The findings were published online Aug. 16 in JAMA Internal Medicine.

Psychiatric News (8/16) reports that even though “there was a small increased risk of preterm birth of children exposed to prenatal antipsychotics, additional analysis suggested this may be due to maternal psychiatric illness and not the medication.”

Related Links:

MedPage Today (requires login and subscription)

Posted in In The News.